DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Sharma P, Callahan MK, Calvo E. et al.
Efficacy and safety of nivolumab plus ipilimumab in previously treated metastatic urothelial carcinoma. presented at the 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016).
National Harbor, MD, USA: 9–13 November 2016
We do not assume any responsibility for the contents of the web pages of other providers.